Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Treasury Shares (2016 - 2025)

Wave Life Sciences' Treasury Shares history spans 10 years, with the latest figure at $1.8 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 113.62% year-over-year to $1.8 million; the TTM value through Dec 2025 reached $1.8 million, up 113.62%, while the annual FY2025 figure was $1.8 million, 113.62% up from the prior year.
  • Treasury Shares reached $1.8 million in Q4 2025 per WVE's latest filing, down from $1.8 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.9 million in Q4 2021 to a low of $614449.0 in Q1 2023.
  • Average Treasury Shares over 5 years is $1.1 million, with a median of $832043.0 recorded in 2024.
  • Peak YoY movement for Treasury Shares: tumbled 50.18% in 2022, then surged 181.15% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $1.9 million in 2021, then crashed by 50.18% to $934342.0 in 2022, then plummeted by 31.76% to $637557.0 in 2023, then soared by 30.5% to $832043.0 in 2024, then surged by 113.62% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for WVE's Treasury Shares are $1.8 million (Q4 2025), $1.8 million (Q3 2025), and $1.8 million (Q2 2025).